RWJ 26240

Drug Profile

RWJ 26240

Alternative Names: MCN 5691

Latest Information Update: 10 Feb 1999

Price : $50

At a glance

  • Originator Ortho-McNeil
  • Class Antihypertensives; Ischaemic heart disorder therapies; Vasodilators
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension

Most Recent Events

  • 10 Feb 1999 MCN 5691 is now called RWJ 26240
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top